U.S. to pay $2.9 billion for an additional 1.4 million doses of Regeneron’s COVID-19 therapy
Shares of Regeneron Pharmaceuticals Inc.
REGN,
+0.88%
gained 2.1% in premarket trading on Wednesday, the day after the company said the U.S. government had purchased an additional 1.4 million doses of its monoclonal antibody treatment for COVID-19 for…
